Intensive insulin therapy for septic shock patients does not show survival benefit

Treating adults with septic shock with intensive insulin therapy to counter elevated blood glucose levels associated with corticosteroid therapy did not result in a reduced risk of in-hospital death, compared to patients who received conventional insulin therapy, according to a study. The researchers also found that adding a 2nd corticosteroid to treatment did not significantly reduce the risk of death within the hospital.

Read the whole article on Science Daily

More from Science Daily